The RMAT designation is intended to expedite the development and evaluation of regenerative medicine therapies.

Researchers have identified a key molecular interaction that accelerates Parkinson’s disease by damaging the brain’s energy ...

About 1 million Americans suffer from Parkinson's disease, with around 90,000 new cases diagnosed each year, according to the ...

FDA fast-tracks novel Parkinson’s cell therapy NouvNeu001, advancing treatment for dopaminergic neuron loss and motor ...

Scientists have identified the role of an ion channel that plays a key part in how cells break down and recycle components, a discovery that could open the door to new treatment strategies for ...

Chinese researchers have developed a new stem cell therapy for Parkinson’s disease which reportedly provides rapid ...

Korean researchers say this common bacterium's journey throughout the body could lead to consequences in the brain.

Two proteins found on the surface of motor neurons in the brain may be essential in the progression of Parkinson's disease, according to new Yale School of Medicine (YSM) research.

After three years of study, the researchers found that alpha-synuclein, a protein closely linked to Parkinson’s disease, forms an abnormal connection with an enzyme called ClpP. This enzyme normally ...

Some Parkinson’s patients may experience strange symptoms, like smell loss and sleep disorders, decades before diagnosis.

Both his neurologist and primary care physician have assured him he does not have Parkinson's or LBD, but are they correct?

Case Western Reserve researchers have found a unique biochemical route that plays a role in Parkinson's disease.